Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

A vaccine against SARS-CoV-2 might represent the most promising approach to halt durably the current COVID-19 pandemic. We believe that anti-CD20 therapy may jeopardise the efficacy of such a vaccine. This is regrettable because patients receiving anti-CD20 therapy (i.e. those with haematologic mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Houot, Roch, Levy, Ronald, Cartron, Guillaume, Armand, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315961/
https://www.ncbi.nlm.nih.gov/pubmed/32619884
http://dx.doi.org/10.1016/j.ejca.2020.06.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315961/
https://www.ncbi.nlm.nih.gov/pubmed/32619884
http://dx.doi.org/10.1016/j.ejca.2020.06.017

Ejemplares similares